Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

(2014) Maxime Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Current and emerging treatment options for the elderly patient with chronic kidney disease

(2014) Robert Fassett   Clinical Interventions in Aging

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

(2013) Paul Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Factors associated with methotrexate dosing and therapeutic decisions in veterans with rheumatoid arthritis

(2013) Bernard Ng et al.   CLINICAL RHEUMATOLOGY

Indexing Glomerular Filtration Rate to Body Surface Area: Clinical Consequences

(2013) Belén Redal-Baigorri et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

(2012) Maxime Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Renal co-morbidity in patients with rheumatic diseases

(2011) Hans-Joachim Anders et al.   ARTHRITIS RESEARCH & THERAPY

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study

(2009) S. M. M. Verstappen et al.   ANNALS OF THE RHEUMATIC DISEASES